y pleaded guilty to US charges of selling adulterated antibiotic, acne, epilepsy and other drugs and agreed to a record $500-million fine.The US fraud, uncovered over eight years, was exposed by a whistle-blowing ex-employee who said Ranbaxy created a complicated trail of falsified records and dangerous manufacturing practices".India's drug industry has come under scrutiny from global regulators